Leigh Anne Siino’s Post

🚨🛬Spherix Global Insights is here in #Chicago for #AAO! Let’s have a great weekend! 🙋🏻♀️What are the CAN’T MISS sessions going on today? American Academy of Ophthalmology 📲DM me, Bob Shewbrooks, or Geoff Dodd to set up some time to meet; we still have some availability on the schedule! 📚And be sure to check out some of our recent #Ophthamology #thoughtleadership: https://lnkd.in/eTci8ws3

🌎Spherix Global Insights’ latest report, Special Topix™: Oral Opportunity in PsO (US) 2024, highlights a shifting landscape in the treatment for moderate-to-severe #PsO. 💊As emerging oral #therapies gain traction, the #study underscores their potential to disrupt the current dominance of #injectable #biologics. 📊Notably, nearly half of surveyed community #dermatologists (n=102) believe that oral agents could achieve efficacy on par with injectable options. 📲For more details on Spherix’s #primarymarketresearch #reports, visit or register here: https://lnkd.in/eUHxNK-Y #pharma #biotech #dermatology #psoriasis #marketresearch #insights Gianna Melendez, M.S. Dermatology Times

🛫I’ll be joining the Spherix Global Insights #Ophthalmology team at the American Academy of 👀Ophthalmology (#AAO) Annual Meeting at 🏙️McCormick Place, #Chicago, IL, from October 18-21, 2024. 📲Reach out to me, Bob Shewbrooks or Geoff Dodd to schedule a time to meet onsite and learn more about how Spherix📊can be an asset to you! #AAO2024 #Ophthalmology #AAOMeeting

🚨Roche/Genentech’s Gazyva Poised to Transform Lupus Nephritis Treatment After Positive Phase III Results🚨 📈 Following positive #topline results from the #PhaseIII #REGENCY trial, #Gazyva is positioned to compete with #Benlysta and #Lupkynis in the #lupusnephritis treatment landscape, pending approval. 👩⚕️ According to 154 US #rheumatologists and #nephrologists surveyed in August as part of Spherix Global Insights’ RealTime Dynamix™: Lupus Nephritis (US) service, #patients with high persistent #proteinuria, steroid dependence, rapidly declining #GFR, frequent #flares, and significant extra-renal manifestations represent the most pressing unmet needs for new treatment options in lupus nephritis. ✅ Roche’s recent Phase III REGENCY trial results for Gazyva (#obinutuzumab) suggest the therapy could directly address these needs. 📲 Get in touch with our #Rheum team here: https://lnkd.in/ebnuKYXJ

🛬 Just two weeks ago, Spherix Global Insights' Dermatology team along with Gianna Melendez, M.S. attended the 2024 #European Academy of #Dermatology and #Venereology (#EADV2024) congress in #Amsterdam. ✅ The teams key takeaways highlights that #hidradenitissuppurativa (#HS) and #atopicdermatitis (#AD) were the main indications of focus at the EADV conference, featuring exciting developments that closely align with Spherix’s #insights. 📊 Overall, EADV 2024 has validated what we have observed: a shift toward early and aggressive #treatment strategies, growing interest in new agents, and the need for deeper understanding of AD. ❗ As we look ahead, these insights will be invaluable for refining our strategies and continuing to provide stakeholders with data that is not only timely but highly relevant to current #therapeutic and #commercial dynamics. #pharma #biotech #biopharma #marketresearch #derm #immunology

🏃♂️ In the fast-paced #biopharma industry, #emerging companies need more than just standard data to navigate their market effectively. 🧬At Spherix Global Insights, we focus on delivering exceptional value tailored to the needs of small to mid-size biopharma organizations looking to effectively navigate market challenges, optimize resource allocation, and enhance overall business strategy. 📈We offer strategic advisement that supports your brand through every phase of its lifecycle, from proof of concept and development to #commercialization. Our insights cover #patients, #prescribers, and #payers, and our strong relationships with key prescribers and #KOLs keep our advice both #clinically and #commercially relevant, ensuring your #brand's success at every stage. 📲Visit our portal and sign up for free to see what's in our 2025 Publication Plan: https://lnkd.in/enrGaifP

📚We must continue to learn. 🛣️Life and careers are a journey, we never get ‘there,’ we just continue to develop and strive to be our very best everyday. 🩷Stay curious, stay humble, stay you. ✅I’m proud to have completed another Pavilion course this summer: #CRO School. 👏🏼Thanks to all in my network that continue to support me, push me, and care.

🎬That’s a wrap on #EADV2024‼️ 🧬#Hidradenitissuppurativa (HS) and #atopicdermatitis (AD) were the main indications of focus at the EADV 2024 conference in #Amsterdam with exciting developments that align well with the Spherix’s insights. 👏🏼What an amazing event, and thanks to all who help make it happen! 👀Keep an eye out for the Spherix Global Insights de-brief from the event in the coming days. Gianna Melendez, M.S. #pharma #biotech #dermatology